ALPS ETF TR - MED BREAKTHGH (SBIO)

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / MED BREAKTHGH
Total 13F shares
1,289,099
Share change
-314,009
Total reported value
$43,376,551
Price per share
$33.64
Number of holders
53
Value change
-$10,685,060
Number of buys
17
Number of sells
22

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q1 2022

As of 31 Mar 2022, ALPS ETF TR - MED BREAKTHGH (SBIO) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,289,099 shares. The largest 10 holders included UBS Group AG, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, Matisse Capital, NTV Asset Management LLC, ROYAL BANK OF CANADA, Strategic Financial Services, Inc,, Beacon Pointe Advisors, LLC, and Tower Research Capital LLC (TRC). This page lists 53 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.